Lamond Capital Partners LLC
Follow13F filer, CIK 1542550, SAN FRANCISCO, CA
Lamond Capital Partners LLC reported $98,504,000 across 11 holdings for the quarter ended 2015-06-30, in a 13F-HR filed 2015-08-07. Its ten largest share positions make up 98.51% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001542550-15-000004
- Period
- 2015-06-30
- Reported value
- $98.5M
- Holdings
- 11
- Top 10 weight
- 98.51%
- New
- 5
- Sold out
- 6
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AXOVANT SCIENCES LTDnew | +692,961 | $14.1M |
| ALEXION PHARMACEUTICALS INCnew | +56,610 | $10.2M |
| HEWLETT PACKARD COnew | +337,000 | $10.1M |
| VIOLIN MEMORY Iadded | +3,486,479 | $8.54M |
| AMGNadded | +49,040 | $7.53M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| GW PHARMACEUTICALS PLCexited | -171,496 | -$15.6M |
| GILDexited | -120,000 | -$11.8M |
| NIMBLE STORAGE INCexited | -360,100 | -$8.03M |
| DEALERTRACK TECHNOLOGIES INCexited | -151,990 | -$5.86M |
| INFOBLOX INCreduced | -199,050 | -$5.22M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2015
Share positions as resolved from 13F-HR 0001542550-15-000004, largest first. % of portfolio is the value over $98,504,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| OCULOCULAR THERAPEUTIX INC | 711,533 | $15M | 15.19% | +291,290 | Timeline | ||
| AMGNAMGEN INC | 96,630 | $14.8M | 15.06% | +49,040 | Timeline | ||
| AXOVANT SCIENCES LTDAXOVANT SCIENCES LTD | 692,961 | $14.1M | 14.34% | new | |||
| ALEXION PHARMACEUTICALS INCALEXION PHARMACEUTICALS INC | 56,610 | $10.2M | 10.39% | new | |||
| HEWLETT PACKARD COHEWLETT PACKARD CO | 337,000 | $10.1M | 10.27% | new | |||
| VIOLIN MEMORY IVIOLIN MEMORY I | 3,934,580 | $9.64M | 9.79% | +3,486,479 | |||
| HORNBECK OFFSHORE SVCS INC NHORNBECK OFFSHORE SVCS INC N | 352,720 | $7.24M | 7.35% | new | |||
| KITE PHARMA INCKITE PHARMA INC | 105,498 | $6.43M | 6.53% | +1,248 | |||
| INFOBLOX INCINFOBLOX INC | 230,872 | $6.05M | 6.14% | -199,050 | |||
| NIVALIS THERAPEUTICS INCNIVALIS THERAPEUTICS INC | 225,000 | $3.41M | 3.46% | new | |||
| BELLICUM PHARMACEUTICALS INCBELLICUM PHARMACEUTICALS INC | 68,780 | $1.46M | 1.49% | +31,780 |
Sold out in Q2 2015
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLC | 171,496 | $15.6M | shares |
| GILDGILEAD SCIENCES INC | 120,000 | $11.8M | shares |
| NIMBLE STORAGE INCNIMBLE STORAGE INC | 360,100 | $8.03M | shares |
| DEALERTRACK TECHNOLOGIES INCDEALERTRACK TECHNOLOGIES INC | 151,990 | $5.86M | shares |
| ZYNGA INC.ZYNGA INC. | 1,580,770 | $4.5M | shares |
| KING DIGITAL ENTMT PLCKING DIGITAL ENTMT PLC | 102,720 | $1.65M | shares |
How Q2 2015 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001542550-15-000004 | base | 2015-08-07 | acceptance time not in the bulk data set |